comparemela.com

Latest Breaking News On - Vicki kelemen - Page 2 : comparemela.com

Cardiff Oncology to Participate in Cowen s 42nd Annual Healthcare Conference

/PRNewswire/ Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a.

Amy jobeVicki kelemenJoyce allaireCardiff oncology incLifesci communicationsPrnewswire cardiff oncology incGastrointestinal genitourinary oncology panelAnnual healthcare conferenceAnnual healthcareCardiff oncologyOncology contact

Cardiff Oncology to Participate in Cowen s 42nd Annual Healthcare Conference

/PRNewswire/ Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a.

Amy jobeVicki kelemenJoyce allaireCardiff oncology incLifesci communicationsPrnewswire cardiff oncology incGastrointestinal genitourinary oncology panelAnnual healthcare conferenceAnnual healthcareCardiff oncologyOncology contactHealth care amp hospitalsMedical pharmaceuticalsTrade show news

Cardiff Oncology Reports Fourth Quarter and Full Year 2021 Results and Recent Highlights

/PRNewswire/ Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a.

United statesHeinz josef lenzActa oncologicaAmy jobeAdam schayowitzJoyce allaireEli lillyErytech pharmaTod smealCharles monahanMark erlanderVicki kelemenCardiff oncology incCrc programPrnewswire cardiff oncology incMedicine team group lead for breast cancer

Cardiff Oncology Reports Fourth Quarter and Full Year 2021 Results and Recent Highlights

/PRNewswire/ Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a.

United statesHeinz josef lenzActa oncologicaAmy jobeAdam schayowitzJoyce allaireEli lillyErytech pharmaTod smealCharles monahanMark erlanderVicki kelemenCardiff oncology incCrc programPrnewswire cardiff oncology incMedicine team group lead for breast cancer

Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

/PRNewswire/ Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage oncology company, developing new precision medicine treatment options for cancer.

Amy jobeVicki kelemenJoyce allaireCardiff oncology incLifesci communicationsPrnewswire cardiff oncology incCardiff oncologyNasdaq listing rulePolo like kinaseOncology contact

vimarsana © 2020. All Rights Reserved.